Amsbio, in association with Nordmark Biochemicals, has expanded its range of Collagenase and Neutral Protease NB enzymes with GMP grade formats and protocols to support advanced tissue dissociation workflows for applications from research to clinical use. These enzymes, derived from Clostridium histolyticum, are critical raw materials for isolating viable cells from complex tissues – an […]
LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to […]
Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Portal Biotech […]
Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, Sweden — Pixelgen Technologies today announced that it has been awarded grant and equity financing of EUR 12.5 M ($14.7 million) from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union’s Horizon Europe program designed to support highly innovative start-ups with […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the […]
Transaction Set to Close in July Synthego Solidly Positioned for Expansion & Growth Redwood City, CA — Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close. This transaction, expected to close in July, will […]
SAN DIEGO — Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. He will succeed Kevin Herde, who is transitioning to an […]
Peachtree Corners, GA – RayBiotech Life, Inc., a global leader in proteomics and translational research tools, is proud to announce a new strategic collaboration with Venebio Group, LLC, a premier life sciences consultancy renowned for its expertise in regulatory strategy and drug safety analytics. Under the newly executed Master Services Agreement (MSA), the two companies will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
